The FusionPlex Core Solid Tumor panel is a targeted next-generation sequencing (NGS) research product that expands on our well-adopted FusionPlex product portfolio to further drive discovery.

Archer’s FusionPlex Core Solid Tumor panel enables simultaneous detection of fusions, splice variants, key SNV/Indels, and relative RNA expression from the same input to drive cost efficiency. The panel features expanded SNV/Indel coverage over key genes, including tumor suppressors. With Anchored Multiplex PCR (AMP™) chemistry at the core and an integrated bioinformatic platform, FusionPlex targeted NGS assays offer streamlined RNA-based analysis from sample to data.